This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | NTUsg |
| Website | http://www.ntu.edu.sg |
| Twitter username | NTUsg |
| Wikipedia page | https://en.wikipedia.org/wiki/Nanyang_Technological_University |
| Instagram username | ntu_sg |
| Org Watch page | https://orgwatch.issarice.com/?organization=Nanyang+Technological+University |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 4 | 70,668 | 67,657 | -41 | 0 | 0 | 70,668 | 70,668 | 70,668 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| Global health | 3 | 100,000 | 66,653 | -41 | 0 | 0 | 0 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| FIXME | 1 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 | 70,668 |
| Donor | Total | 2018 | 2015 | 2014 | 2010 |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 199,958.79 | 0.00 | 100,000.00 | -41.21 | 100,000.00 |
| Foundational Questions Institute (filter this donee) | 70,668.00 | 70,668.00 | 0.00 | 0.00 | 0.00 |
| Total | 270,626.79 | 70,668.00 | 100,000.00 | -41.21 | 100,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 4) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Foundational Questions Institute | 70,668.00 | 3 | FIXME | https://fqxi.org/grants/large/awardees/view/__details/2018/elliott | -- | Project title: The role of quantum effects in simplifying adaptive agents. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 1 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to make a stable and child-friendly mixture of the antibiotic amoxicillin for treating pneumonia in developing countries; Aid type: Project-type interventions. Affected regions: Asia. | |
| Bill and Melinda Gates Foundation | -41.21 | 4 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to use magnetic nanoparticles with blood samples to attract and amplify hemozoin, a byproduct of malaria parasites found in infected red blood cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to use magnetic nanoparticles with blood samples to attract and amplify hemozoin, a byproduct of malaria parasites found in infected red blood cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |